| abstract |
The present invention relates to a novel product of formula (I) as a medicament, in particular as a MET inhibitor, In which Ra represents H, Hal, aryl, or heteroaryl, which are optionally substituted; Rb represents H, Rc, —COORc—CO—Rc, or —CO—NRcRd; Rc represents alkyl, cycloalkyl, heterocycloalkyl, aryl, and heteroaryl, all of which are optionally substituted; Rd represents H, alk, or a cycloalkyl group; and all possible It exists in isomeric form as well as its salt. |